Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment.
In an update from uniQure, they report that their experimental gene therapy, AMT-130, has the potential to slow Huntington’s ...
A new study published in Brain Sciences provides evidence that dopamine promotes movement by directly altering the excitability of key neurons in the brain’s motor circuitry. The research identifies a ...
Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment.
A global clinical trial for a new Huntington's disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL ...